| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1014811607 |
| P356 | DOI | 10.1007/S11886-015-0693-6 |
| P698 | PubMed publication ID | 26768743 |
| P2093 | author name string | Thomas J Povsic | |
| P2860 | cites work | Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies | Q81851071 |
| Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling | Q83323467 | ||
| A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction | Q85063680 | ||
| A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study | Q86853989 | ||
| Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function. | Q50774320 | ||
| Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. | Q50981942 | ||
| CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. | Q53254720 | ||
| Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial). | Q53455003 | ||
| Circulating progenitor cells can be reliably identified on the basis of aldehyde dehydrogenase activity. | Q53512458 | ||
| Comparative effects of mesenchymal progenitor cells, endothelial progenitor cells, or their combination on myocardial infarct regeneration and cardiac function. | Q53518783 | ||
| Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial | Q56610959 | ||
| Cardiopoietic Stem Cell Therapy in Heart Failure | Q57779306 | ||
| Functional impairment of hematopoietic progenitor cells in patients with coronary heart disease | Q58863641 | ||
| Reparative Effects of Allogeneic Mesenchymal Precursor Cells Delivered Transendocardially in Experimental Nonischemic Cardiomyopathy | Q58865316 | ||
| Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled | Q59260969 | ||
| Mesenchymal Stem Cells Provide Better Results Than Hematopoietic Precursors for the Treatment of Myocardial Infarction | Q59938198 | ||
| Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials | Q61649093 | ||
| Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation | Q61776512 | ||
| Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Int | Q61942700 | ||
| Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy | Q63285824 | ||
| Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia | Q73395331 | ||
| Chimerism of the transplanted heart | Q77452324 | ||
| Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts | Q77885470 | ||
| Autologous bone-marrow stem-cell transplantation for myocardial regeneration | Q78761519 | ||
| Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction | Q79289222 | ||
| CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells | Q79317344 | ||
| Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies | Q79826696 | ||
| Sustained effect of autologous bone marrow mononuclear cell injection in patients with refractory angina pectoris and chronic myocardial ischemia: twelve-month follow-up results | Q80333368 | ||
| Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction | Q22250889 | ||
| Evidence for cardiomyocyte renewal in humans | Q24594522 | ||
| The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes | Q28199117 | ||
| Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
| Heart regeneration in zebrafish | Q29619776 | ||
| Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial | Q29620043 | ||
| Paracrine mechanisms in adult stem cell signaling and therapy | Q29620571 | ||
| Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. | Q30444845 | ||
| Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction | Q30496413 | ||
| Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction | Q30824170 | ||
| Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial | Q31033745 | ||
| Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging | Q33193903 | ||
| Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysis | Q33258314 | ||
| Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction | Q33273736 | ||
| Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis | Q33285990 | ||
| Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review | Q33340205 | ||
| Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. | Q33374961 | ||
| Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial | Q33950809 | ||
| The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. | Q34010010 | ||
| Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial | Q34074673 | ||
| Patients with coronary artery disease not amenable to traditional revascularization: prevalence and 3-year mortality. | Q34113038 | ||
| Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial | Q34332467 | ||
| Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a meta-analysis of randomised controlled clinical trials | Q34372154 | ||
| Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial | Q34467911 | ||
| Intramyocardial injection of bone marrow mononuclear cells in chronic myocardial ischemia patients after previous placebo injection improves myocardial perfusion and anginal symptoms: an intra-patient comparison | Q34471244 | ||
| Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial | Q34544699 | ||
| Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina | Q34547211 | ||
| Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial | Q34569443 | ||
| Meta-analysis of stem cell therapy in chronic ischemic cardiomyopathy. | Q34691429 | ||
| Bone Marrow Stem Cell Treatment for Ischemic Heart Disease in Patients with No Option of Revascularization: A Systematic Review and Meta-Analysis | Q34804229 | ||
| Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization | Q35111623 | ||
| Predictors of long-term clinical endpoints in patients with refractory angina | Q35135665 | ||
| Intramyocardial, autologous CD34+ cell therapy for refractory angina | Q35308043 | ||
| Meta-analysis of cell therapy trials for patients with heart failure | Q35551127 | ||
| Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells | Q35799278 | ||
| Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study | Q36322384 | ||
| Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial | Q36694346 | ||
| Mesenchymal stem cells for vascular regeneration | Q37000697 | ||
| Aging and disease as modifiers of efficacy of cell therapy | Q37183949 | ||
| Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial design | Q37340293 | ||
| Depletion of circulating progenitor cells precedes overt diabetes: a substudy from the VA enhanced fitness trial | Q37418276 | ||
| Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction | Q37444118 | ||
| Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis | Q38021450 | ||
| Treatment of refractory angina in patients not suitable for revascularization | Q38173640 | ||
| Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial | Q38381605 | ||
| PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI. | Q38384991 | ||
| Repeated Intramyocardial Bone Marrow Cell Injection in Previously Responding Patients With Refractory Angina Again Improves Myocardial Perfusion, Anginal Complaints, and Quality of Life | Q38406348 | ||
| Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials | Q39222871 | ||
| Long-term survival in patients with refractory angina | Q39227491 | ||
| Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial | Q39272735 | ||
| Circulating endothelial progenitor cells, vascular function, and cardiovascular risk | Q39513285 | ||
| Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised cl | Q40525372 | ||
| Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia | Q40608302 | ||
| Mobilization of bone marrow-derived Oct-4+ SSEA-4+ very small embryonic-like stem cells in patients with acute myocardial infarction | Q41189527 | ||
| A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure | Q41608655 | ||
| Common endothelial progenitor cell assays identify discrete endothelial progenitor cell populations | Q41907027 | ||
| Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease | Q42485863 | ||
| Mobilization of endothelial progenitor cells in patients with acute myocardial infarction | Q43636896 | ||
| One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study). | Q44237365 | ||
| Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure | Q44270472 | ||
| Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction | Q44392643 | ||
| Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure | Q44411377 | ||
| Stem cell therapy is a promising tool for refractory angina: a meta-analysis of randomized controlled trials | Q44493479 | ||
| Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up | Q44697038 | ||
| Autologous peripheral stem cell transplantation in patients with congestive heart failure due to ischemic heart disease | Q44799055 | ||
| Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. | Q45075945 | ||
| Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety | Q46700940 | ||
| Repeat Cell Therapy for Refractory Angina: Déjà vu All Over Again? | Q47991504 | ||
| Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial). | Q48039597 | ||
| Efficacy of a device to narrow the coronary sinus in refractory angina | Q48050685 | ||
| Long term effects of intramyocardial bone marrow cell injection on anginal symptoms and quality of life in patients with chronic myocardial ischemia | Q48253059 | ||
| Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. | Q48414650 | ||
| Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina: one-year follow-up | Q48459462 | ||
| Effect of intracoronary injection of mononuclear bone marrow stem cells on left ventricular function in patients with acute myocardial infarction | Q48831721 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 17 | |
| P577 | publication date | 2016-01-01 | |
| P1433 | published in | Current cardiology reports | Q26842345 |
| P1476 | title | Current State of Stem Cell Therapy for Ischemic Heart Disease | |
| P478 | volume | 18 |
| Q38688641 | A Novel Role for CAMKK1 in the Regulation of the Mesenchymal Stem Cell Secretome. |
| Q64104219 | Effect of stem cell transplantation on patients with ischemic heart failure: a systematic review and meta-analysis of randomized controlled trials |
| Q55649548 | Midterm outcomes of transmyocardial laser revascularization with intramyocardial injection of adipose derived stromal cells for severe refractory angina. |
| Q52685704 | Stem cell therapy targeting the right ventricle in pulmonary arterial hypertension: is it a potential avenue of therapy? |
| Q57730655 | Strategies for non-invasive imaging of polymeric biomaterial in vascular tissue engineering and regenerative medicine using ultrasound and photoacoustic techniques |
Search more.